Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Drug-Related Side Effects and Adverse Reactions × Pharmaceutical Preparations × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Neoplasm Metastasis 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

apatinib 3 Ifosfamide 2 Filgrastim 2 Etoposide 2 selinexor 1 glucarpidase 1 camrelizumab 1 Vincristine 1 Radiotherapy 1 Procarbazine 1 Pharmaceutical Preparations 1 Methotrexate 1 Lomustine 1 Imatinib Mesylate 1 Genetic Therapy 1 Fibroblast Growth Factor 7 1 Drug Combinations 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04138381 2023-03-27

SeliGIST

Grupo Espanol de Investigacion en Sarcomas

Phase 1/2 Unknown

Neoplasm Metastasis, Sarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡